| Document |
Document Title |
|
WO/2019/069828A1 |
Provided is an optically active 2,3-bisphosphinopyrazine derivative represented by general formula (1). (In the formula, R1 denotes a group selected from among a branched alkyl group having 3 or more carbon atoms, an adamantyl group, an ...
|
|
WO/2019/067635A1 |
The disclosure provides methods for sequencing nucleic acids using, including with nucleotide analogs and subsequently appended labels.
|
|
WO/2019/057050A1 |
The present invention relates to the technical field of porous composite material preparation, and provides a slurry synthesis method for a porous composite framework material. A mass ratio of a solvent to a solid reactant is controlled,...
|
|
WO/2019/049775A1 |
Disclosed is a lithium boron sulfate compound represented by formula (I). In formula (I), R0 represents a C1–20 alkoxy group, or a group represented by formula (II). In formula (II), * indicates a bond position.
|
|
WO/2019/044478A1 |
The invention is an electroconductive substance comprising a complex containing a rubeanic acid ligand and a copper ion. The copper ion included in the complex comprises a copper (I) ion. In addition, this electroconductive substance is ...
|
|
WO/2019/046761A1 |
Disclosed herein are compound embodiments that are useful for treating a variety of diseases, particularly neurological diseases, motor neuron diseases, copper deficiency-related diseases, and/or mitochondrial deficiencies. The compound ...
|
|
WO/2019/031232A1 |
A production method for a 2,3-bisphosphinopyrazine derivative, characterized by including a first step, in which a base is added to and reacted with a liquid containing a 2,3-dihalogenopyrazine represented by general formula (1), a hydro...
|
|
WO/2019/030304A1 |
The invention relates to ylide-functionalised phosphane ligands, the production of same and use in transition metal compounds, as well as the use of same as catalysts in organic reactions.
|
|
WO/2019/024707A1 |
Metal nanoparticles are directly synthesized on polymers comprising a plurality of thiol groups to form compositions useful as electron microscopy tags.
|
|
WO/2019/021144A1 |
A process of hydrogel preparation by gelation of water with only one amino acid, which is Lhistidine, where during gelation for 15 hours, multiple thread-like nano fibers of n- number of metal-organic co-ordinated polymers come together ...
|
|
WO/2019/021143A1 |
An anti-microbial hydrogel comprising n-number of metal organic coordinated compound with one silver ion sandwiched between two L-histidine molecules, arranged in a particular manner, with π-π stacking in the upper and the lower side w...
|
|
WO/2019/012918A1 |
The method according to the present invention for producing an optically active 2,3-bisphosphinopyrazine derivative comprises: a step for preparing solution A which contains a 2,3-dihalogenopyrazine represented by general formula (1) and...
|
|
WO/2019/005876A1 |
Disclosed herein are gold compounds and methods of use thereof as antibacterials. Specifically exemplified are methods of treating a Mycobacterium infection by administering therapeutically effective amounts of the gold compounds.
|
|
WO/2019/006327A1 |
The present disclosure relates gold carbene naphthoquinone compounds and salts thereof. In some aspects, these compounds can be used to treat cancer including cancers which are resistant to one or more other chemotherapeutic agents such ...
|
|
WO/2018/236199A1 |
The present invention relates to a ligand for forming a copper complex, a ligand for forming a palladium complex, a copper complex catalyst, a palladium complex catalyst, a production method therefor and a use thereof.
|
|
WO/2018/223180A1 |
The present invention relates to compounds that are useful as radiopharmaceuticals and radioimaging agents which bear a radionuclide-chelating agent. These coordinated compounds are useful in radiotherapy and diagnostic imaging. The inve...
|
|
WO/2018/217637A1 |
Au(III) complexes for [18F] trifluoromethylation and methods for producing the same are disclosed. A gold complex comprises Au(CF3)2LR, wherein L comprises a solubility supporting ligand and R comprises an organic substituent. The Au(III...
|
|
WO/2018/212356A1 |
Stable perovskite films having substantially-no phase transition within a predetermined temperature range are disclosed. In the films, formation of carrier traps is suppressed. Thermally stable perovskite solar cells and light-emitting d...
|
|
WO/2018/206595A1 |
The invention relates to novel cuprate compounds which are suitable as luminous substances in an organic light emitting diode (OLED). The invention further relates to methods for producing said novel cuprate compounds, and to organic lig...
|
|
WO/2018/204461A1 |
Inorganic-organic hybrid structures having both ionic and coordinate bonds in a molecular cluster possessing the features of structural diversity, high luminescence and stability, and excellent dispersibility, suitable for use as lightin...
|
|
WO/2018/192686A1 |
The invention relates to a method for producing, amongst other things, amino-acid and/or hydroxycarboxylic-acid metal chelates, a solvent-free mixture of at least one metal oxide, metal hydroxide, metal carbonate or oxalate, and the soli...
|
|
WO/2018/186490A1 |
Provided are a novel naphthalocyanine compound having strong absorption in the near infrared region, very little absorption in the visible light region, high fastness such as light resistance and heat resistance, and good solubility in o...
|
|
WO/2018/159505A1 |
Provided are: a dissimilar-metal salt assembly which is a dendrimer capable of having a large number of, i.e., four or more types, particularly five or more types of dissimilar-metal salt compounds having dissimilar metals precisely inte...
|
|
WO/2018/153330A1 |
Disclosed in the present invention are a biflavonoid-copper complex, a preparation method and an application thereof. In the present invention, amentoflavone is used as a ligand and a copper ion is used as a central ion, an amentoflavone...
|
|
WO/2018/144101A1 |
Described herein are labeling agents, specifically [11C]fluoroform, [11C]difluoromethane, [11C]fluoromethyl iodide, [11C]fluoromethyl bromide, [11C]fluoromethyl chloride, [11C]fluoromethyl trifluoromethansulfonate, [11C]difluoromethyl io...
|
|
WO/2018/139470A1 |
There is a desire for a technique wherein a sodium 2,2,6,6-tetramethylpiperidide (Na-TMP) compound can be economically and efficiently synthesized in a short time under mild conditions by a simple procedure including a small number of st...
|
|
WO/2018/140235A1 |
Vapor deposition processes for forming thin films comprising gold on a substrate in a reaction space are provided. The processes can be cyclical vapor deposition processes, such as atomic layer deposition (ALD) processes. The processes c...
|
|
WO/2018/113782A1 |
Disclosed is a metal-organic complex of the general formula M(L)n(L1)m(1), wherein M(L)n is selected from one of the general formulas (2) and (3), and M is a metal atom; L is a monoanionic monodenate chelate ligand; L1 is another ligand;...
|
|
WO/2018/107425A1 |
A composition comprising resin and dye mixture, an article having a polymer layer formed from the composition, and a color filter formed from the composition are developed. The dye mixture contains a phthalocyanine compound and another d...
|
|
WO/2018/108110A1 |
Disclosed are a metal organic complex and the use thereof, a mixture, and an organic electronic device. The structure of the metal organic complex is as shown by general formula (1), and the definitions of the symbols in the general form...
|
|
WO/2018/099698A1 |
The invention relates to a process for the preparation of triaryl-organo borates from boronic ester and the use of these substances in photo initiator systems, photopolymer compositions comprising such photo initiator systems, a holograp...
|
|
WO/2018/102125A1 |
A non-hydroxylic-solvent soluble silver complex comprises a reducible silver ion complexed with an α-oxy carboxylate and an oxime compound. The non-hydroxylic-solvent soluble silver complex can be represented by the following formula (I...
|
|
WO/2018/100560A1 |
The present invention concerns Au and Cu-based mononuclear coordination compounds, drug formulations thereof, the relating synthesis and encapsulation method in macromolecules or supramolecular aggregates or nanostructures, as well as th...
|
|
WO/2018/100561A1 |
The present invention relates to mononuclear coordination compounds of Au and Cu, pharmaceutical formulations based thereof, the relative method of synthesis and encapsulation of the compounds in macromolecules, supramolecular aggregates...
|
|
WO/2018/089554A1 |
Molecules compounds are provided having the structure in Formula I, or a salt thereof, wherein n1 is independently 0, 1, 2, or 3; n2 is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20; n3 is from 0, 1, 2, or 3...
|
|
WO/2018/073400A1 |
The present invention relates to a crystalline metal organic framework which comprises repeating units of formula (RR)-(IA)or (SS)-(IA)or (RS)-(IA) or (SR)-(IA); or alternatively of formula (RR)-(IB) or (SS)-(IB) or (RS)-(IB) or (SR)-(IB...
|
|
WO/2018/056237A1 |
Provided are a new dielectric material and an electrostrictive material. The dielectric material or electrostrictive material comprises a charge separated-type non-coulombic ionic solid in which complex cations comprising metal elements ...
|
|
WO/2018/039794A1 |
The present application provides a hydrodefluorination process for the preparation of hydrofluoroalkenes by catalyzed substitution of one or more F atoms of a C2-C30 fluoroalkene, or a C2-C10 fluoroalkene, with one or more H atoms using ...
|
|
WO/2018/031234A1 |
A non-hydroxylic-solvent soluble silver complex has a reducible silver ion complexed with an α-oxy carboxylate and a primary alkylamine. This non-hydroxylic-solvent soluble silver complex can be represented by the following formula (I):...
|
|
WO/2018/028312A1 |
A method of preparing luminescent nano-sheets includes preparing a precursor emulsion solution containing a metal halide and RNH 3X, with the molar ratio of metal halide to RNH 3X in a range of approximately 0.6 to approximately 0.8; dem...
|
|
WO/2018/031235A1 |
A non-hydroxylic-solvent soluble silver complex comprises a reducible silver ion complexed with an α-oxy carboxylate and a 5- or 6-membered N- heteroaromatic compound. The non-hydroxylic-solvent soluble silver complex can be represented...
|
|
WO/2018/021406A1 |
Provided are: a novel metal complex; and an electron-transporting material which uses said metal complex and can be formed by a wet process during the manufacture of an organic electroluminescent device having a multilayer structure. Thi...
|
|
WO/2018/021882A1 |
According to the present invention, a compound represented by chemical formula 1 is characterized by being coordinated with a metal ion, thereby enabling a bidirectional or multi-directional organometallic complex to be formed. Therefore...
|
|
WO/2018/015493A1 |
A metal complex has the general formula (I), in which: R-Z is a HDAC inhibitor in which Z a terminal hydroxamate group; M is a redox active metal; n+ is the positive charge on the complex cation; Bn- is a balancing counterion; Z binds to...
|
|
WO/2018/016650A1 |
The present disclosure provides: a method for producing a metal organic structure nanosheet, in which in the case where a bilayer membrane forms a super-swollen lamellar phase in a solvent, a sheet-like metal organic structure is formed ...
|
|
WO/2017/208944A1 |
The objective of the present invention is to provide: a nonaqueous electrolyte solution which is capable of exhibiting high output characteristics at low temperatures even when a battery has been used to a certain extent, while exhibitin...
|
|
WO/2017/205092A1 |
Highly thermal and photo-stable inorganic-organic hybrid phosphor compounds, in which a copper (I) halide module is coordinated with a multi-dentate organic ligand. Also disclosed are semiconductor and light emitting devices comprising t...
|
|
WO/2017/186924A1 |
Stable crystal forms comprising lithium ions and the conjugate base of an organic acid which is in the form of anhydrous coordination polymer that exhibit improved in vivo performance with respect to lithium carbonate.
|
|
WO/2017/178992A1 |
This invention relates to a metal complex of an imidazo[l,2-a]pyridine ligand and/or a metal complex of an imidazo[l,2-a] pyridine ligand derivative and/or an analogue thereof, wherein said metal complexes are for use in treating cancer....
|
|
WO/2017/132156A1 |
A monomer is provided for a thermoset molding compound. The monomer is also polymerized with conventional monomers to form thermoplastic polymers. Graphene oxide is used to chelate metal ions to form a graphene oxide chelate that is coup...
|
